Abstract:Tumor necrosis factor α (TNF-α) is a cytokine that plays a major role in several chronic inflammatory disorders. Anti-TNF-α therapy has been widely employed in clinic. However, the source of natural human TNF-α is so limited that it's difficult to meet the research needs. The purpose of this project is to construct an effective prokaryotic expression system for recombinant human TNF α (rhTNF-α). The sequence of hTNF-α is retrieved from Entrez Gene at NCBI. The whole gene of hTNF-α is optimized, synthezied by a company, inserted into the expression vector pET-28a (+) and expressed in E. coli BL21 (DE3). The N-terminus of hTNF-α contains a His-tag and a TEV protease site. The 10 ×His-tag is used to purify the protein by Ni+-NTA, and the TEV protease site is used to remove the His-tag. The soluble expression conditions of hTNF-α were optimized by orthogonal array design. The large-scale fermentation was carried out under optimized conditions. The expressed rhTNF-α protein was purified by Ni+ affinity chromatography. Then, the 10 ×His tag was removed by TEV protease treatment and followed though Ni+ column again. The purification effect was identified by SDS-PAGE and western blot. The biological activity of rhTNF-α was evaluated by MTT method with L929 cells as target cells. The recombinant cloning and expressing plasmid of rhTNF-α was successfully constructed. The outflow from the Ni column was the purified rhTNF-α, showing single polypeptide band by SDS-PAGE. The productivity of purified rhTNF-α is about 4.17 mg/L. L929 cell cytotoxicity assay showed IC50<10 ng/mL. An effective prokaryotic expression system for rhTNF-α was successfully constructed in our study. The application of two-step Ni+ affinity chromatography purification method could produce soluble rhTNF-α protein with high purity and relative bioactivity.

PRODUCTION OF RECOMBINANT PORCINE TUMOR-NECROSIS-FACTOR-ALPHA IN A NOVEL ESCHERICHIA-COLI EXPRESSION SYSTEM

Production of recombinant porcine tumor necrosis factor alpha in a novel E. coli expression system.

Porcine Tumor Necrosis Factor Alpha: Cloning with the Polymerase Chain Reaction and Determination of the Nucleotide Sequence.

Equine Tumor-Necrosis-Factor-Alpha - Cloning And Expression In Escherichia-Coli, Generation Of Monoclonal-Antibodies, And Development Of A Sensitive Enzyme-Linked-Immunosorbent-Assay

Expression of Recombinant Feline Tumor-Necrosis-Factor is Toxic to Escherichia-Coli

Expression in Escherichia Coli of Anti-Human Tumor Necrosis Factor Alpha Scfv under the Control of T7 Promoter.

Expression and Purification of Recombinant Human Tumor Necrosis Factor α in Escherichia Coli

Expression of Recombinant Human Tumor Necrosis Factor-Α in a Baculovirus Expression System

[Gene Modification and High Prokaryotic Expression of Porcine Interferon Alpha-1].

[Site-Directed Mutation of PoIFN-alpha and Its Expression in Escherichia Coli].

Expression, Purification, and Characterization of Recombinant Protein GX1-rmhTNFα

[Cloning, expression and identification of recombinant fusion protein GX1-rmhTNFalpha].

A Strategy for High-Level Expression of a Single-Chain Variable Fragment Against TNFα by Subcloning Antibody Variable Regions from the Phage Display Vector Pcantab 5E into Pbv220.

Molecular Cloning of a Novel Porcine Interferon-αand Its Expression in Escherichia coli

Expression of porcine alpha-prothymosin in E.coli and its biological activity identification

Construction of Eukaryotic Expression Vector and Establishment of Cell Line Solely Producing Human TNF-alpha in Secretory Form

PURIFICATION AND PARTIAL AMINO ACID SEQUENCE OF RABBIT TUMOR NECROSIS FACTOR

A Tumor Necrosis Factor (TNF) Receptor-Igg Heavy Chain Chimeric Protein As a Bivalent Antagonist of TNF Activity.

Expression and Bioactivity Analysis of TNF30, a TNFα Nanobody, in Escherichia Coli

Production of Bioactive, SUMO-modified, and Native-Like TNF-α of the Rhesus Monkey, Macaca Mulatta , in Escherichia Coli

High Expression of Soluble Tumor Necrosis Factor-α (TNF-α) in E. coli and Preparation of Specific Antibody against TNF-α